Skip to main content
. 2021 Nov 30;8:781596. doi: 10.3389/fmed.2021.781596

Table 4.

Association of serum CYR61 and hospital stays in COPD patients.

CYR61 Cases, n Longer hospital stays, n (%) RR (95%) P
Low 81 21 (25.9) 1 -
High 69 38 (55.1) 2.124 (1.388, 3.250) <0.001

According to quartile, serum CYR61 was classified as Low group (<410.0 pg/ml) and High group (≥410.0 pg/ml), hospital stays were divided into Short group (<10 days) and Long group (≥10 days).

RR, relative risk.